Your browser doesn't support javascript.
COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge.
Cochran, Willa; Salto-Alejandre, Sonsoles; Barker, Lindsay; Langlee, Julie; Freed, Kristin; Carter, Debra; Bannon, Jaclyn; Goddard, Dillon; Mostafa, Heba; Werbel, William; Shah, Pali; Segev, Dorry; Brennan, Daniel; Avery, Robin.
  • Cochran W; Johns Hopkins Hospital, Baltimore, MD.
  • Salto-Alejandre S; Virgen del Rocio University Hospital, Seville, Spain.
  • Barker L; Johns Hopkins Hospital, Baltimore, MD.
  • Langlee J; Johns Hopkins Hospital, Baltimore, MD.
  • Freed K; Johns Hopkins Hospital, Baltimore, MD.
  • Carter D; Johns Hopkins Hospital, Baltimore, MD.
  • Bannon J; Johns Hopkins Hospital, Baltimore, MD.
  • Goddard D; Johns Hopkins Hospital, Baltimore, MD.
  • Mostafa H; Department of Medicine, Johns Hopkins, Baltimore, MD.
  • Werbel W; Department of Medicine, Johns Hopkins, Baltimore, MD.
  • Shah P; Department of Medicine, Johns Hopkins, Baltimore, MD.
  • Segev D; NYU Langone Hospital, New York City, NY.
  • Brennan D; Department of Medicine, Johns Hopkins, Baltimore, MD.
  • Avery R; Department of Medicine, Johns Hopkins, Baltimore, MD.
Transplantation ; 2022 Oct 13.
Article in English | MEDLINE | ID: covidwho-2229011

Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Year: 2022 Document Type: Article Affiliation country: TP.0000000000004418

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Year: 2022 Document Type: Article Affiliation country: TP.0000000000004418